Brunner and the recently retired President of GlaxoSmithKline (GSK), Colin Mackenzie, have created a special partnership to help brands in the Consumer Packaged Goods and OTC worlds solve digital acceleration issues related to marketing and brand engagement.

The partnership with our former client combines Brunner’s expertise in digital performance marketing and digital transformation with Mackenzie’s experience running one of the largest consumer health care companies in North America. During the Brunner-GSK relationship, the two organizations worked together to launch Abreva® via an aggressive digital strategy, which resulted in the brand reaching U.S. $100MM sales faster than any other in GSK’s history at that time. In fact, Brunner worked together with GSK on more than 20 brands over 2 decades ranging from Aquafresh® to Nicorette® to TUMS®.

Brunner, along with Colin Mackenzie’s insights and strategic counsel can offer brands the following solutions:

  • Marketing enhancements to quickly turn around momentum lost during the COVID-19 crisis.
  • Determining your data maturity and creating a plan for improved digital delivery across all touchpoints.
  • Agile test and learn strategies that help brands do more with less.

To learn more about the partnership and how it can benefit your brand, please contact Patrick Culhane, Director, Business Development and Strategy at [email protected].